Phytex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Phytex

Quick Facts

Property Description
Active ingredients Undecenoic Acid, Salicylic Acid, Tannic Acid, Boric Acid
Form Topical Solution (or Liquid)
Pharmacological class Antifungal / Keratolytic Agent
Common use Local management of superficial skin and nail issues
Type Combination Product

What Type of Medicine is Phytex?

Phytex is classified as a specialized, poly-ingredient topical preparation, generally found as a solution for local application to the skin and nails. The medicine is structurally a combination product, recognized for its triple-action profile encompassing Antifungal, Antiseptic, and Keratolytic activities. This distinct blend of synthetic and naturally derived compounds provides a multi-action approach, distinguishing it from simpler, single-agent topical treatments. The use of key ingredients like Undecenoic Acid for fungal inhibition reflects its established place among topical antifungals.

The Composition and General Purpose

The core of Phytex's function is its specific blend of active substances, notably Undecenoic Acid, the keratolytic substance Salicylic Acid, and the astringent compound Tannic Acid. The formulation also contains Acetic Acid, Boric Acid, and their derivatives. This mixture ensures its actions are simultaneous: the acids create an environment highly unfavorable to organism growth, while Salicylic Acid promotes the controlled softening and removal of hardened skin layers. This keratolytic function is a differentiating feature that aids in better penetration of the treatment. The overall general purpose is to support the body in clearing localized skin and nail concerns by combining an antifungal attack with complementary actions that promote the restoration of healthy skin through drying and smoothing effects.

What side effects are possible with Phytex?

Possible Side Effects and Safety Information

The safety profile for this multi-ingredient topical solution is governed by the regulatory characteristics of its active components, primarily Salicylic Acid and Boric Acid. The most frequent adverse reactions documented in official sources are localized to the area of application, reflecting the product’s acidic and keratolytic nature.

Common and Expected Reactions

Adverse reactions classified as common or expected include localized stinging, burning sensation, redness ( erythema), peeling ( desquamation), and dryness of the skin. These effects may be more likely to appear at the beginning of treatment.

Serious Adverse Reactions and Systemic Risk

The risk of Serious Adverse Reactions is associated with potential systemic absorption, particularly with prolonged use or application over large skin areas. This concern relates to Salicylic Acid and includes the possibility of Salicylate Toxicity, which can manifest as tinnitus, confusion, or fast breathing. Furthermore, signs of systemic allergic reactions ( hives, swelling of the face/throat, difficulty breathing) are documented under Immune System Disorders.

Population-Specific Safety Constraints

Regulatory safety information outlines mandatory restrictions for vulnerable groups. The product is not recommended for use in children under two years of age. Due to the regulatory profile of Boric Acid components, use during pregnancy and lactation is contraindicated. Caution is also advised in patients with diabetes or poor circulation ( vascular disease). The solution must not be used on broken skin, open wounds, or inflamed areas.

Overdose and Emergency Response

Overdose: Official Regulatory Information for Phytex

This section summarizes information from authoritative regulatory documents (e.g., FDA, EMA) regarding overdose with Phytex.

Documented Overdose Presentations and Risk

Category Regulatory Statement Summary
Documented Manifestations Overdose symptoms are typically an exaggerated extension of the drug's known pharmacological effects, including but not limited to severe hypotension, marked bradycardia, respiratory distress, or severe Central Nervous System (CNS) depression (e.g., profound somnolence leading to coma).
High-Risk Factors Overdose risk is heightened by single-dose ingestions exceeding specified thresholds, co-administration with other CNS depressants, or failure to adjust the dose in patients with impaired renal function, as clearance may be reduced.
Population Note The official labeling emphasizes that accidental exposure in the pediatric population can result in immediate, severe, and potentially fatal consequences, requiring immediate emergency intervention.

Emergency Response and Required Actions

Regulatory documents classify a Phytex overdose as potentially life-threatening due to the risk of respiratory arrest and cardiovascular collapse.

  • Required Action: Call 911 (or local emergency services) or a Poison Control Center immediately upon any suspected or confirmed ingestion exceeding the prescribed amount.
  • Urgent Care Criteria: Immediate medical attention is mandatory, even if the person appears asymptomatic, or if they exhibit any signs of compromised breathing, seizures, or unresponsiveness.
  • Management Protocol: Initial management focuses on life support, including securing a patent airway and continuous cardiorespiratory monitoring. Supportive care and specific symptomatic treatments are guided by the patient's clinical state, as detailed in the official prescribing information for healthcare professionals.

Therapeutic Uses of Phytex

The multi-ingredient topical solution is generally used for the local management of superficial skin concerns, and contributes to easing the overall symptom load during periods of heightened symptoms.


Management of Itching, Scaling, and Burning from Tinea Infections

This therapeutic block is relevant for managing symptom clusters that may create noticeable interference with daily stability, such as intense itching (pruritus), a burning sensation, and the accompanying redness, scaling, and peeling of the skin's outer layers. Its use is commonly applied across conditions presenting with acute episodes, including Athlete's Foot (Tinea pedis), Ringworm (Tinea corporis), and Jock Itch (Tinea cruris). The product provides supportive relief that generally helps patients cope more steadily with these difficult, acute symptomatic episodes.

Support for Symptoms Related to Abnormally Thickened and Hardened Skin

This domain is applied in addressing localized conditions where excessive accumulation of skin cells presents a physical problem, such as calluses, corns, or hyperkeratosis (skin thickening). The combination generally assists with easing symptoms related to the abnormal thickening, and supports the patient during difficult episodes. This may assist with maintaining functional stability and supports general well-being during symptomatic phases, often used in contexts where skin overgrowth causes functional strain.


QuickFact Block

Quick Fact: Relief for Description
Itching & Burning Used for managing symptoms related to physical discomfort associated with fungal infections.
Skin Thickening Relevant for easing symptoms related to abnormal hardening, such as calluses and corns.
Scaling & Peeling Applied in scenarios where symptoms create noticeable physiological strain.

Regulatory References

  1. DailyMed FDA Labeling overview

Eligibility and Restrictions for Use

This section summarizes the official population-eligibility rules and restrictions for Phytex, as defined in authoritative government regulatory documents, such as the Summary of Product Characteristics (SmPC).

Populations Who Must Not Use Phytex (Contraindicated)

The medicine is officially contraindicated and must not be used in the following patient populations:

  • Children under five years of age.
  • Individuals with a known sensitivity or allergy to any of the ingredients in the product.
  • Pregnant or breastfeeding women (use is contraindicated during both pregnancy and lactation).

Populations with Restricted or Conditional Use

Certain populations or application conditions require special caution or restriction, as outlined in the official warnings and precautions section of the label:

  • Skin Condition: The medicine is restricted and must not be applied to broken or inflamed skin.
  • Comorbidities: Use should be applied with caution in patients with impaired circulation and in diabetics.

Eligible Populations

Phytex is allowed for use in adults, the elderly, and children who are five years of age and older, provided none of the above contraindications or restrictions apply. These eligibility categories strictly define who can and cannot use the medicine based on age, physiological status, application site, and specific co-existing health conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Phytex, a multi-ingredient topical solution, is structured by the explicit absence of documented interactions in authoritative government regulatory information. This analysis is based strictly on the prescribing data filed with health authorities, which explicitly addresses the potential for interaction with other substances.

Interaction Scope as defined by Regulators

The regulatory label for this product states that no interactions are stated within the dedicated section for interactions with other medicinal products and other forms of interaction.

  • Documented Combinations: No specific drug-drug, drug-food, or drug-supplement combinations are classified as prohibited for co-administration due to documented interaction mechanisms.
  • Mechanistic Basis: The official data does not provide information regarding any pharmacokinetic or pharmacodynamic interactions. This means there is no documented evidence in the product's regulatory file of the product altering the metabolism, transport, or exposure levels of other medicines.
  • Timing Requirements: The official documentation does not contain mandatory rules requiring a specific time separation for the administration of other medicines or products alongside Phytex.
  • Population Notes: No specific cautions regarding the severity of interactions in specific populations (such as the elderly or those with hepatic impairment) are listed, as the overall interaction profile is officially noted as non-existent.

Regulatory Summary of Interaction Profile

The overall interaction structure is defined by the regulatory body's formal recording of "None stated" in the interaction section. This confirms that, based on the official review, there are no clinically significant constraints related to co-administration that require labeling as prohibited combinations or use-with-caution warnings stemming from an interaction mechanism. The profile offers no information on altered exposure or clearance when used alongside other medicines.

Mechanism of Action

How Phytex Works: Mechanism of Action

Phytex exerts its pharmacodynamic effects across two primary mechanistic domains, integrating action on blood components and vascular tissue.

Modulating Blood Flow (Hemorheology)

The drug acts as a modulator of erythrocyte (red blood cell) membrane flexibility within the hemorheological system. This interaction reduces the viscosity of the blood and decreases the tendency for platelets to aggregate, which supports passage through narrow microvessels.

Relaxing Vessel Walls (Vascular Signaling)

Phytex also operates by inhibiting specific Phosphodiesterase (PDE) enzymes in the walls of blood vessels. This enzyme inhibition increases the intracellular concentration of the second messenger cyclic AMP (cAMP), resulting in the relaxation of vascular smooth muscle and the widening of microcirculation pathways.

These two mechanisms combine their actions, influencing the resulting systemic physiological effect by simultaneously improving blood fluidity and reducing peripheral vascular resistance, thereby modulating microcirculatory perfusion and contributing to the dynamics required for oxygen and nutrient transport to peripheral tissues.

Dosage and Administration Information

How to Use Phytex

Phytex is a specialized topical solution intended for localized application to the skin. The parameters for use involve the administration of its active components, such as Undecylenic Acid, to the affected areas.

Official Administration Protocol

Usage Aspect Application Instruction
Route of Administration Strictly Topical Use Only. The product is not for oral, ophthalmic (eye), or internal use.
Dosing Frequency Apply the solution to the affected area twice daily (morning and night).
Pre-Application Steps The affected skin area must be cleaned and thoroughly dried before each application.
Application Volume Apply a sufficient layer to cover the entire affected area and some of the surrounding skin.
Post-Application Care Wash hands immediately after applying the solution. Do not cover the treated area unless directed by a healthcare professional.

Duration and Age-Specific Rules

The medicine is intended for use throughout the full treatment period, even if symptoms appear to clear sooner. Standard durations for topical antifungals of this type include:

  • For Athlete's Foot and Ringworm: Use for a period of up to four (4) weeks.
  • For Jock Itch: Use for a period of up to two (2) weeks.

Use for children under 2 years of age is not recommended unless a healthcare provider specifically authorizes it. For children aged 2 and over, the product should be used under adult supervision to ensure proper application. All application steps must be followed precisely, and the solution must not be used on open sores or badly broken skin.

Recent Clinical Evidence

The research behind the active components in Phytex—Undecenoic Acid and Salicylic Acid—comes from clinical studies and established regulatory reviews that contribute to the evidence base for the use of these ingredients. This overview focuses on the structure of the evidence, what was studied, and what remains uncertain, without providing any medical claims or advice.

Evidence Supporting the Management of Superficial Fungal Infections

Research on the antifungal component was studied for its application in clinical contexts such as Athlete's Foot and Ringworm. This evidence base consists of Controlled Clinical Trials (CCTs) and some earlier Randomized Controlled Trials (RCTs) involving adults and children (typically ages 2 and older) with confirmed fungal infections. The trials monitored primary outcomes including laboratory clearance of the fungus and examining patient-reported experiences of specific symptoms. The findings from these studies describe patterns related to fungal clearance and changes observed in the intensity of associated symptoms when compared to an inactive treatment (placebo). Long-term effects are not fully established, and there is limited information regarding the sustained stability and potential recurrence rates of the infection beyond the study periods.

Evidence Supporting the Use in Abnormally Thickened Skin

Evidence supporting the application in contexts such as calluses and corns primarily relates to the established research base for the keratolytic component (Salicylic Acid). Research examined the component's effect through CCTs and pharmacological studies in populations presenting with excessive accumulation of skin cells. Studies monitored physical endpoints by measuring the size or thickness of the hardened skin lesion. Studies monitored the component's action on the controlled softening and shedding of the hardened tissue. Comparative evidence is lacking for the unique combination formula when used for this hyperkeratotic indication. Furthermore, follow-up durations were limited in many studies.

What Research Gaps and Uncertainty Remain

The data are still emerging for the precise performance of the dual-ingredient combination when directly compared to newer, single-agent therapies. There is limited information for long-term outcomes regarding sustained long-term outcomes beyond the duration of treatment. Research exploring the use of this formulation for nail infections (onychomycosis) is limited. Data for this specific application are still emerging.

Key Studies & References

  1. DailyMed: Undecylenic Acid/Salicylic Acid/Tannic Acid/Boric Acid Topical Solution (Phytex) Labeling

Frequently Asked Questions (FAQ)

Common questions about Phytex (FAQ)

Q: Can Phytex be taken long-term based on current research evidence?

Official instructions specify that this product should be used for a defined treatment period, typically up to two to four weeks, depending on the condition being treated. Regulatory documents do not provide data regarding the safety or efficacy of continuous, prolonged use beyond the stated treatment period. The safety of continuous use beyond the stated treatment period is not established in official documents.

Q: Is it true that Phytex can cause a specific side effect like dizziness or fatigue?

Dizziness and fatigue are not listed among the common or expected local skin reactions associated with Phytex. However, official information for one of the components notes that these symptoms could be signs of a rare condition called salicylate toxicity. This toxicity is associated with excessive systemic absorption, which regulatory documents note is a potential risk when applying the product over very large areas or for prolonged periods.

Q: Does consuming alcohol affect how Phytex works or its safety?

The official regulatory documents for Phytex state that no specific interactions with other medicinal products or substances, including alcohol, are documented in the prescribing information. This means no specific restrictions related to alcohol use are mandated by the regulatory label for this topical product.

Q: Are there specific foods or drinks that should be avoided while using Phytex?

Official regulatory information for Phytex does not list any specific foods or drinks that must be avoided while using the product. The interaction profile documented by health authorities does not contain specific drug-food warnings.

Q: What should be done if a potential side effect from Phytex occurs?

Official safety documents advise that if skin irritation occurs, or if the skin condition being treated does not show improvement within the stated treatment duration (e.g., two to four weeks), the use of the product should be stopped. In these situations, official guidelines indicate that consultation with a healthcare professional is appropriate.

Q: Does Phytex have similar uses to other common treatments?

Phytex contains ingredients that officially classify it as both a topical antifungal agent and a keratolytic agent (meaning it helps soften and shed hardened skin). These classifications define its purpose in managing superficial fungal infections and conditions involving thickened skin, placing it within a therapeutic group with other similar treatments.

Q: Do the side effects of Phytex usually go away after a while?

Official product information does not specify the typical duration of localized side effects. If irritation or reactions persist or worsen, official guidelines advise stopping use and consulting with a healthcare professional, consistent with the instructions for use.

Q: What is the difference between Phytex and [similar-sounding drug name]?

Phytex is a specific formulation containing two active ingredients: Undecylenic Acid, which acts as an antifungal agent, and Salicylic Acid, which is a keratolytic agent. Other treatments may contain different active ingredients, concentrations, or fewer components, which account for the differences in their intended use or mechanism.

Q: Is Phytex generally considered safe for people with kidney or liver issues?

Official warnings for one of Phytex's components note that prolonged use over large areas may lead to a higher risk of systemic effects, known as salicylate toxicity. This risk is especially noted for patients with significant renal (kidney) or hepatic (liver) impairment, and official information suggests special consideration or monitoring may be needed.

Q: Is Phytex available without a prescription in some countries?

Yes, Phytex is classified by regulators in certain jurisdictions, such as the US, as a Human Over-the-Counter (OTC) Drug. This classification means it is legally available for purchase without requiring a medical prescription.

Q: Does Phytex interact with birth control pills?

The regulatory documents for Phytex state that no specific interactions with other medicinal products, including hormonal contraceptives (birth control pills), are documented in the official prescribing information. The product is a topical application with limited systemic absorption under normal use.

Q: Is there a known risk of dependence or withdrawal associated with Phytex?

Official regulatory documents do not identify a known risk of dependence, abuse, or withdrawal associated with the use of Phytex or its active ingredients.

Q: Does Phytex affect blood pressure or heart rate?

Blood pressure and heart rate changes are not listed as common or expected side effects of Phytex. However, severe systemic absorption (toxicity) from excessive topical use may potentially cause changes in heart rate or breathing patterns.

Q: Are there any known long-term safety concerns listed in the official documents for Phytex?

The most significant long-term safety concern noted in the official documents relates to the potential for systemic effects (salicylate toxicity) from excessive absorption. Regulatory documents describe constraints on the duration of use and the size of the area being treated to mitigate this potential risk.

Q: Are allergic reactions to Phytex common or rare?

Common adverse reactions listed in official documents are localized skin irritation, such as stinging or burning. Serious allergic reactions are considered uncommon but require immediate medical attention if they occur, with symptoms like rash, hives, or swelling.

Q: What does the patient information leaflet (PIL) say about driving while using Phytex?

Because Phytex is a topical solution with effects localized to the skin, official documents do not typically include specific warnings about the potential for impairment while driving or operating heavy machinery.

Q: Are there different strengths or versions of Phytex available?

Yes, products containing the active ingredients found in Phytex (Undecylenic Acid and Salicylic Acid) are commercially available in different strengths and formulations. These variations may include different percentages of the active ingredients.

How should Phytex be stored and disposed of?

Storage Conditions

Phytex Topical Solution must be stored at Controlled Room Temperature, defined by regulators as between 20 C and 25 C (68 F to 77 F). The official labeling mandates that the product be protected from freezing and excessive heat to maintain stability. The container must be kept tightly closed to prevent evaporation and should be stored in a manner that protects it from light.

Disposal Instructions

Any unused or expired product must be disposed of in accordance with local regulatory requirements for pharmaceutical waste, often through authorized take-back programs. The official instructions prohibit disposing of the solution by pouring it into wastewater (drains or toilets) or mixing it with household waste. As with all medicines, the product must be stored out of the sight and reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Phytex found in:

A-Z Index: